CD209 and viral infectious disease: All in all, we established an animal component-free in vitro model to generate primary CD11c+CD209+-moDCs by use of hPL, which is a valuable tool to study viral infections and interactions in vitro and under more defined conditions compared to FCS-generated DCs.